Cantor Fitzgerald Stock Recommendations and Price Targets

This is a list of recent ratings by Cantor Fitzgerald.

Date	Company Name	Action	Current Price	Price Target	Rating	Impact on Share Price
4/25/2024	AMED Amedisys	Reiterated Rating	$92.00	$101.00	Neutral ➝ Neutral	Low
4/25/2024	TER Teradyne	Reiterated Rating	$114.00	$110.00	Neutral ➝ Neutral	Low
4/25/2024	LRCX Lam Research	Reiterated Rating	$925.00	$1,100.00	Neutral ➝ Neutral	Low
4/25/2024	ENVX Enovix	Reiterated Rating	$6.00	$30.00	Overweight ➝ Overweight	Low
4/25/2024	HUM Humana	Lower Price Target	$306.00	$391.00 ➝ $360.00	Neutral ➝ Neutral	Low
4/25/2024	BMRN BioMarin Pharmaceutical	Reiterated Rating	$81.00	$110.00	Overweight ➝ Overweight	Low
4/24/2024	MTLS Materialise	Initiated Coverage	$5.00	$9.50	Overweight	Low
4/24/2024	STX Seagate Technology	Boost Price Target	$86.00	$95.00 ➝ $100.00	Neutral ➝ Neutral	Low
4/24/2024	ANNX Annexon	Reiterated Rating	$5.00		Overweight	Low
4/24/2024	ITCI Intra-Cellular Therapies	Reiterated Rating	$73.00	$120.00	Overweight ➝ Overweight	Low
4/24/2024	TXN Texas Instruments	Reiterated Rating	$177.00	$180.00	Neutral ➝ Neutral	Low
4/23/2024	INCY Incyte	Initiated Coverage	$52.00		Neutral	Low
4/23/2024	CDTX Cidara Therapeutics	Reiterated Rating	$13.00		Overweight	Low
4/23/2024	ABEO Abeona Therapeutics	Reiterated Rating	$3.00	$36.00	Overweight ➝ Overweight	N/A
4/18/2024	CMPS COMPASS Pathways	Reiterated Rating	$8.00		Overweight	Low
4/18/2024	NVO Novo Nordisk A/S	Reiterated Rating	$127.00	$160.00	Overweight ➝ Overweight	Low
4/18/2024	MRK Merck & Co., Inc.	Reiterated Rating	$131.00	$135.00	Overweight ➝ Overweight	Low
4/18/2024	GPCR Structure Therapeutics	Reiterated Rating	$39.00	$65.00	Overweight ➝ Overweight	Low
4/18/2024	BHVN Biohaven	Reiterated Rating	$39.00		Overweight	Low
4/18/2024	ASND Ascendis Pharma A/S	Reiterated Rating	$136.00	$173.00	Overweight ➝ Overweight	Low
4/18/2024	TSHA Taysha Gene Therapies	Reiterated Rating	$2.00	$7.00	Overweight ➝ Overweight	Low
4/17/2024	ZS Zscaler	Reiterated Rating	$177.00	$230.00	Neutral ➝ Neutral	N/A
4/17/2024	PANW Palo Alto Networks	Reiterated Rating	$291.00	$350.00	Overweight ➝ Overweight	N/A
4/17/2024	NET Cloudflare	Reiterated Rating	$88.00	$100.00	Neutral ➝ Neutral	N/A
4/17/2024	FTNT Fortinet	Reiterated Rating	$64.00	$65.00	Neutral ➝ Neutral	N/A
4/17/2024	DDOG Datadog	Reiterated Rating	$131.00	$150.00	Overweight ➝ Overweight	N/A
4/17/2024	CYBR CyberArk Software	Reiterated Rating	$243.00	$300.00	Overweight ➝ Overweight	N/A
4/17/2024	CRWD CrowdStrike	Reiterated Rating	$304.00	$400.00	Overweight ➝ Overweight	N/A
4/17/2024	COUR Coursera	Reiterated Rating	$12.00	$26.00	Overweight ➝ Overweight	Low
4/16/2024	KVYO Klaviyo	Initiated Coverage	$24.00	$31.00	Overweight	Low
4/15/2024	VFS VinFast Auto	Reiterated Rating	$3.00	$9.00	Overweight ➝ Overweight	Low
4/15/2024	PFE Pfizer	Reiterated Rating	$25.00	$45.00	Overweight ➝ Overweight	Low
4/15/2024	JNJ Johnson & Johnson	Reiterated Rating	$146.00	$215.00	Overweight ➝ Overweight	Low
4/15/2024	LLY Eli Lilly and Company	Reiterated Rating	$734.00	$815.00	Overweight ➝ Overweight	Low
4/15/2024	REGN Regeneron Pharmaceuticals	Reiterated Rating	$883.00	$925.00	Neutral ➝ Neutral	Low
4/12/2024	MYNZ Mainz Biomed	Reiterated Rating	$1.00		Neutral	Low
4/12/2024	PTCT PTC Therapeutics	Reiterated Rating	$29.00	$45.00	Overweight ➝ Overweight	Low
4/12/2024	HRMY Harmony Biosciences	Reiterated Rating	$29.00	$49.00	Overweight ➝ Overweight	Low
4/12/2024	MRVL Marvell Technology	Reiterated Rating	$70.00	$85.00	Overweight ➝ Overweight	Low
4/12/2024	PSNY Polestar Automotive Holding UK	Reiterated Rating	$1.00	$5.00	Overweight ➝ Overweight	Low
4/12/2024	ALXO ALX Oncology	Reiterated Rating	$17.00		Overweight	Low
4/11/2024	SOUN SoundHound AI	Upgrade	$4.00	$4.90	Underweight ➝ Neutral	Low
4/10/2024	HUM Humana	Reiterated Rating	$306.00	$391.00	Neutral ➝ Neutral	Low
4/10/2024	HCAT Health Catalyst	Reiterated Rating	$6.00	$16.00	Overweight ➝ Overweight	Low
4/10/2024	HCA HCA Healthcare	Reiterated Rating	$307.00	$335.00	Overweight ➝ Overweight	Low
4/10/2024	ELV Elevance Health	Reiterated Rating	$537.00	$580.00	Overweight ➝ Overweight	Low
4/10/2024	CVS CVS Health	Reiterated Rating	$67.00	$87.00	Overweight ➝ Overweight	Low
4/10/2024	CI The Cigna Group	Reiterated Rating	$354.00	$384.00	Overweight ➝ Overweight	Low
4/10/2024	XENE Xenon Pharmaceuticals	Reiterated Rating	$40.00	$65.00	Overweight ➝ Overweight	Low
4/10/2024	NBIX Neurocrine Biosciences	Reiterated Rating	$136.00	$155.00	Overweight ➝ Overweight	Low
4/10/2024	MRNS Marinus Pharmaceuticals	Reiterated Rating	$1.00	$28.00	Overweight ➝ Overweight	Low
4/10/2024	LBPH Longboard Pharmaceuticals	Reiterated Rating	$20.00	$60.00	Overweight ➝ Overweight	Low
4/10/2024	JAZZ Jazz Pharmaceuticals	Reiterated Rating	$109.00	$180.00	Overweight ➝ Overweight	Low
4/10/2024	AXSM Axsome Therapeutics	Reiterated Rating	$72.00	$107.00	Overweight ➝ Overweight	Low
4/10/2024	ACAD ACADIA Pharmaceuticals	Reiterated Rating	$17.00	$37.00	Overweight ➝ Overweight	Low
4/10/2024	AWH Aspira Women's Health	Reiterated Rating	$3.00	$3.30	Neutral ➝ Neutral	Low
4/10/2024	UNH UnitedHealth Group	Reiterated Rating	$495.00	$591.00	Overweight ➝ Overweight	Low
4/10/2024	UHS Universal Health Services	Reiterated Rating	$166.00	$156.00	Underweight ➝ Underweight	Low
4/10/2024	THC Tenet Healthcare	Reiterated Rating	$96.00	$104.00	Overweight ➝ Overweight	Low
4/10/2024	TBRG TruBridge	Reiterated Rating	$8.00	$24.00	Overweight ➝ Overweight	Low
4/10/2024	SGRY Surgery Partners	Reiterated Rating	$25.00	$43.00	Overweight ➝ Overweight	Low
4/10/2024	RCM R1 RCM	Reiterated Rating	$12.00	$20.00	Overweight ➝ Overweight	Low
4/10/2024	BHVN Biohaven	Reiterated Rating	$39.00		Overweight	Low
4/10/2024	PRTA Prothena	Reiterated Rating	$21.00		Overweight	Low
4/9/2024	GPCR Structure Therapeutics	Initiated Coverage	$39.00	$65.00	Overweight	Low
4/9/2024	VINC Vincerx Pharma	Reiterated Rating	$1.00		Overweight	Low
4/9/2024	AGIO Agios Pharmaceuticals	Reiterated Rating	$31.00		Overweight	Low
4/8/2024	AMAT Applied Materials	Upgrade	$203.00	$220.00 ➝ $260.00	Neutral ➝ Overweight	Low
4/8/2024	GFS GLOBALFOUNDRIES	Reiterated Rating	$48.00	$70.00 ➝ $55.00	Overweight ➝ Neutral	Low
4/8/2024	WDC Western Digital	Boost Price Target	$71.00	$70.00 ➝ $100.00	Overweight ➝ Overweight	Low
4/8/2024	TXN Texas Instruments	Boost Price Target	$177.00	$170.00 ➝ $180.00	Neutral ➝ Neutral	Low
4/8/2024	QCOM QUALCOMM	Boost Price Target	$166.00	$150.00 ➝ $190.00	Neutral ➝ Neutral	Low
4/8/2024	MU Micron Technology	Boost Price Target	$115.00	$135.00 ➝ $150.00	Overweight ➝ Overweight	Low
4/8/2024	LRCX Lam Research	Boost Price Target	$925.00	$900.00 ➝ $1,100.00	Neutral ➝ Neutral	Low
4/8/2024	KLAC KLA	Boost Price Target	$706.00	$625.00 ➝ $800.00	Neutral ➝ Neutral	Low
4/8/2024	NXPI NXP Semiconductors	Boost Price Target	$243.00	$270.00 ➝ $290.00	Overweight ➝ Overweight	Low
4/5/2024	MRK Merck & Co., Inc.	Reiterated Rating	$131.00	$135.00	Overweight ➝ Overweight	Low
4/5/2024	ETNB 89bio	Reiterated Rating	$8.00	$29.00	Overweight ➝ Overweight	Low
4/5/2024	RARE Ultragenyx Pharmaceutical	Reiterated Rating	$44.00	$107.00	Overweight ➝ Overweight	Low
4/5/2024	CABA Cabaletta Bio	Reiterated Rating	$11.00	$50.00	Overweight ➝ Overweight	Low
4/4/2024	TNGX Tango Therapeutics	Initiated Coverage	$7.00		Overweight	Low
4/4/2024	HUM Humana	Reiterated Rating	$306.00	$391.00	Neutral ➝ Neutral	Low
4/4/2024	ELV Elevance Health	Reiterated Rating	$537.00	$580.00	Overweight ➝ Overweight	Low
4/4/2024	CVS CVS Health	Reiterated Rating	$67.00	$87.00	Overweight ➝ Overweight	Low
4/4/2024	CNC Centene	Reiterated Rating	$74.00	$90.00	Overweight ➝ Overweight	Low
4/4/2024	PRE Prenetics Global	Lower Price Target	$5.00	$10.00 ➝ $9.00	Overweight ➝ Overweight	Low
4/4/2024	ATAI Atai Life Sciences	Reiterated Rating	$2.00		Overweight	N/A
4/4/2024	STOK Stoke Therapeutics	Reiterated Rating	$12.00		Overweight	Low
4/4/2024	SPRO Spero Therapeutics	Reiterated Rating	$1.00		Overweight	Low
4/4/2024	UNH UnitedHealth Group	Reiterated Rating	$495.00	$591.00	Overweight ➝ Overweight	Low
4/4/2024	MOH Molina Healthcare	Reiterated Rating	$342.00	$406.00	Overweight ➝ Overweight	Low
4/3/2024	LEGN Legend Biotech	Initiated Coverage	$45.00	$82.00	Overweight	Low
4/3/2024	RIVN Rivian Automotive	Reiterated Rating	$9.00	$23.00	Overweight ➝ Overweight	Low
4/3/2024	PRCH Porch Group	Boost Price Target	$3.00	$3.00 ➝ $5.00	Overweight ➝ Overweight	Low
4/3/2024	ANNX Annexon	Reiterated Rating	$5.00		Overweight	Low
4/3/2024	INTC Intel	Reiterated Rating	$32.00	$50.00	Neutral ➝ Neutral	Low
4/1/2024	MIGI Mawson Infrastructure Group	Reiterated Rating	$1.00	$1.00	Neutral ➝ Neutral	Low
4/1/2024	PFE Pfizer	Reiterated Rating	$25.00	$45.00	Overweight ➝ Overweight	Low
4/1/2024	NVO Novo Nordisk A/S	Reiterated Rating	$127.00	$160.00	Overweight ➝ Overweight	Low
4/1/2024	LLY Eli Lilly and Company	Reiterated Rating	$734.00	$815.00	Overweight ➝ Overweight	Low